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A backside protein-surface imprinting process is presented herein as a novel way to generate speciﬁc synthetic antibody materials. The template is 
covalently bonded to a carboxylated-PVC supporting ﬁlm previously cast on gold, let to interact with charged monomers and surrounded next by 
another thick polymer. This polymer is then covalently attached to a transducing element and the backside of this structure (supporting ﬁlm plus 
template) is removed as a regular “tape”. The new sensing layer is exposed after the full template removal, showing a high density of re-binding positions, 
as evidenced by SEM. To ensure that the templates have been eﬃciently removed, this re-binding layer was cleaned further with a proteolytic  enzyme  
and  solution  washout.  The  ﬁnal  material  was  named  MAPS,  as  in  the  back-side reading  of  SPAM,  because  it  acts  as  a  back-side  imprinting  of  this  
recent  approach.  It  was  able  to generate, for the  ﬁrst time, a  speciﬁc response to a  complex biomolecule  from  a  synthetic material. Non-imprinted  
materials  (NIMs)  were  also  produced  as  blank  and  were  used  as  a  control  of  the imprinting process. All chemical modiﬁcations were followed by 
electrochemical techniques. This was done  on  a  supporting  ﬁlm  and  transducing  element  of  both  MAPS  and  NIM.  Only  the  MAPS-based device  
responded  to  oxLDL  and  the  sensing  layer  was  insensitive  to  other  serum  proteins,  such  as myoglobin  and  haemoglobin.  Linear  behaviour  
between  log(C,  mg  mL-1)  versus   charged  tranfer resistance (RCT, U) was observed by electrochemical impedance spectroscopy (EIS). Calibrations made 
in 
Fetal Calf Serum (FCS) were linear from 2.5 to 12.5 mg mL-1  (RCT  ¼ 946.12 x log C + 1590.7) with an 
R-squared of 0.9966. Overall, these were promising results towards the design of materials acting close to the natural antibodies and applied to practical 
use of clinical interest. 
 
1. Introduction 
An antibody (Ab) or immunoglobulin (Ig) is a protein molecule of the 
immune system that binds with a high degree of aﬃnity and speci city to a 
speci c target species called antigen.1 This feature justi es its intensive 
use as a reagent in diagnostic assays and therapeutics, with a great 
impact on the improve- ment of health and welfare in both humans and 
animals.2,3 This is possible due to well-established experimental 
protocols leading to their production on a high scale, but their inherent 
complexity and cost4 has guided researchers towards nding new 
synthetic pathways for Ab designing. 
The most successful synthesis route for obtaining antibodies makes use 
of molecular imprinting technology,5 rst discovered in 1931 by Polyakov,6 
and demonstrated later in 1972 by Wulﬀ and Sarhan.7,8 The enthusiasm of 
researchers within this eld of biomimetic materials started then and 
lasts until today.9 In brief, an imprinted polymer is produced by 
growing a rigid 
polymeric network around a target molecule. The imprinted sites are 
generated once the template exits the polymer matrix, theoretically 
matching the size and shape of the target. Despite many years of progress, 
targeting big-sized molecules such as proteins by molecular imprinting 
technology is still a chal- lenge.10–12 Size, complexity, conformational 
exibility and solu- bility of proteins are main obstacles, which have been 
surpassed by using bulk, epitopes or surface imprinting approaches.10–23 
Surface imprinting seems by far the most successful approach in 
plastic Ab design. It consists mostly in attaching the template to the 
surface, enabling a pre-polymerization stage where functional monomers 
are allowed to bind to the template molecule, and polymerize the 
monomeric material by controlled/living free radical 
polymerization.17,22,23 In general, the covalent immobilization of the 
template molecules at the surface of solid substrates oﬀers some 
advantages: it enables imprinting templates that are insoluble in the pre-
polymeriza- tion mixture and minimizes template aggregation, thus leading 
    to more homogeneous binding sites.17 
But the materials produced by surface imprinting contain areas that 
are able to interact with foreign-proteins by means of non-speci c 
interactions, which in turn reduce the selectivity of the material for its 
target compound. Promoting a chemical 
  
 
diﬀerentiation between the binding site and the surrounding surface 
was recently proposed to reduce this eﬀect. This was made by adding 
charged positions to the binding sites and polymerizing the 
surrounding area with neutral monomers.24 The obtained biomimetic 
materials were named Smart Plastic Antibody Materials (SPAMs), 
showing enhanced aﬃnity and selectivity for the targeted protein. 
However, SPAMs shared a common diﬃculty in surface imprinting 
which is the control of the thickness of the polymer layer. When the 
polymer thickness is higher than the template size, measured when 
attached to the receptor surface, the template to be imprinted is unable 
to come out of the polymeric network. Controlling the polymer 
thickness in surface imprinting is therefore fundamental because the 
number of binding sites and the dimensions of these sites are directly 
correlated with this simple feature. It is however a diﬃcult task because the 
protein templates are usually smaller than 10 nm and the template may 
be attached to the receptor surface in diﬀerent positions, which 
according to the protein conforma- tion above the surface may lead to 
diﬀerent polymer thickness requirements within the same material. 
To overcome the dependency of the polymer thickness, this work 
reports a backside imprinted layer of the SPAM plastic antibody, this 
time named MAPS (Materials Antibody Plastic Smart), the backside 
reading of SPAM. The cross-section of the imprinted material where the 
protein displays a higher density is the z-axis plane corresponding to the 
protein covalent bond. If this layer is able to come out, all proteins would be 
at the same distance for exiting the material. Overall, this new approach is 
expected to ensure that all proteins are in contact with the outer surface and 
able to exit the imprinted matrix, thus generating surfaces with a high 
density of rebinding sites. 
Herein, this new concept is applied to target oxidized Low- Density 
Lipoprotein (oxLDL) fractions, composed of diﬀerent particles of oxidized 
LDL. Increased plasma levels of oxLDL are associated with 
atherosclerosis which promotes vascular dysfunction by exerting 
direct cytotoxicity on endothelial cells and increases chemotactic 
properties for monocytes and macrophages and consequent 
transformation into foam cells, which contributes to atherogenesis. The 
oxLDL level in circu- lating plasma is commonly recognized as an 
important predictive marker of risk to a cardiovascular event, therefore, 
novel approaches with simple procedures and low cost are highly 
urgent and would be greatly appreciated. 
In brief, oxLDL was covalently bond to a supporting lm of 
All chemical modi cations of the supporting lm and the transducing 
element were followed by electrochemical tech- niques, both in MAPS 
and NIM materials. The resulting devices were also evaluated by 
electrochemical techniques and further tested in a Fetal-Calf Serum (FCS) 
background, nearing its application to real biological samples. 
 
2. Experimental section 
2.1. Apparatus 
Electrochemical measurements were conducted in a potentio- 
stat/galvanostat from Metrohm Autolab/PGSTAT302N with an 
impedimetric module of the same brand. It was controlled by NOVA 
so ware. SPEs used were purchased from Drop Sense (DRP-C220AT), 
having working and counter electrodes made of gold and reference 
electrode and electrical contacts made of silver. The diameter of the 
working electrode was 4 mm. 
Surface analysis was carried out by using a Scanning Electron Microscope 
(SEM) of JEOL, JSM-6010LA InTouchScope in vacuum mode. 
Morphological analysis was conducted using a Scanning Electron 
Microscope (SEM), JSM-6010LA in vacuum mode. An ultracentrifuge from 
Beckman, 50Ti rotor, L-8, was used in the preparation of serum samples. 
 
2.2. Reagents 
All  chemicals  were  of  analytical  grade  and  de-ionized  water (conductivity  
<0.1  mS  cm-1)  was  used.  Poly(vinyl  chloride) carboxylated  (PVC–COOH,  
Fluka),  2-nitrophenyl  octylether (ONPOE,  Fluka),  tetrahydrofuran  (THF,  
Aldrich),  N-hydroxy- succinimide   (NHS,   Fluka),   N-(3-
dimethylaminopropyl)-N0 - ethylcarbodiimide  hydrochloride  (EDAC,  Sigma),  
ethylenedi- amine (EA, Merck), vinyl benzoate (VB, Aldrich), (vinylbenzyl) 
trimethylammonium chloride (VB+, Acros Organics), benzoyl peroxide  
(BPO,  Himedia),  methacrylic  acid  (MAA,  Aldrich), ethylene glycol 
dimethacrylate (EGDMA, TCI), 3-mercaptopro- pionic  acid  (MPA,  Sigma),  
proteinase  K  from  tritirachium album (Sigma), ethyelenodiamine 
tetraacetic acid (EDTA, diso- dium salt), copper sulphate (CuSO4), myoglobin 
equine skeletal muscle  (Myo,  Sigma-Aldrich)  and  human  haemoglobin  
(Hb, Sigma-Aldrich) were used. 
Native LDL was obtained from patients as described later and 
dialysed prior to its oxidation. oxLDL was obtained by copper based 
oxidation of LDL and was further analyzed with regard to its MDA 
content, by measuring thiobarbituric acid 
25,26 
carboxylated-PVC cast on a gold support of a screen-printed electrode 
(SPE), no. 1, let to interact with charged monomers and covered by a 
neutral polymeric network. The outer surface of this polymer was then 
covalently attached to another trans- ducing element that was another 
SPE (no. 2), binding the two SPEs together. These two SPEs were separated 
a er stripping out SPE-1, which extracted the carboxylated-PVC lm along with 
the oxLDL. The backside of the chemical structure set-up in SPE-1 was 
now exposed as the top-side of SPE-2. Extensive template extraction was 
further ensured by an enzymatic reac- tion. Non-imprinted materials 
(NIMs) were also produced as blank and were used as the control for the 
imprinting process. 
reactive substances (TBARS). 
 
2.3. Solutions 
The buﬀer used throughout this work was PBS, pH 7.2, and was prepared by 
mixing 0.9% NaCl, 0.3% Na2HPO4, 0.2% H2PO4 and 0.38% (w/v) NaOH. For the 
oxidation of LDL, native LDL from 4 to 6 mg mL-1 prepared in buﬀer, 20 
mmol L-1 CuSO4 solution in water, and 1 mmol L
-1 EDTA in buﬀer were 
used. 
For the synthesis of MAPS 0.1 g of PVC–COOH and 0.12 g of ONPOE 
dissolved in rv1.5 mL THF were used. For the activation of carboxylic 
functions 25 mmol L-1  NHS and 50 mmol L-1 EDAC, both prepared in 
water, were used. The 4 mg ml-1 oxLDL 
  
 
solution used to assemble MAPS was prepared in water. EA solutions 
were prepared in ionized water with a 0.5 mol L-1 concentration. The 
monomer solutions were prepared in water, having 5.0 x 10-3 mol L-1 (VB, 
MAA or EGDMA) or 1.0 x 10-2 mol L-1  (VB+) concentrations. The radical 
initiator BPO was 
5.0 x 10-4 mol L-1, freshly prepared in water. MPA solution was 
1  x  10-3  mol  L-1  prepared  in  ionized  water.  Proteinase  K solutions 
were 500 mg mL-1 prepared by suitable dilution of the commercial reagent 
in buﬀer. Stock solutions of oxLDL had a 4 mg ml-1  concentration and 
were prepared in buﬀer. Less concentrated standards were prepared by 
accurate dilution of the previous solution in the same buﬀer. The 
selectivity study required the preparation of oxLDL, Myo, Hb and native LDL, 
all with concentrations of 50 mg mL-1 and prepared in buﬀer. EIS assays 
used a solution containing 5.0 mmol L-1 of [Fe(CN)6]
3- and 5.0 mmol L-1 
of [Fe(CN)6]
4-, prepared in buﬀer. 
 
2.4. Isolation of native LDL 
Blood samples were collected from healthy volunteers, of both sexes, a er 
fasting for 12 hours, with cholesterol and triglyc- eride plasma 
concentrations ranging within the normal levels (cholesterol <240 mg 
dL-1  and triglycerides <160 mg dL-1). These  procedures  were  
conducted  according  to  the  Ethics Committee on research involving 
humans of the Institute of Biomedical  Sciences,  University  of  S a˜o  
Paulo,  Brazil,  and approved in protocol no. 1033/CEP. 
Blood was collected in vacuum tubes (BD Vacutainer), con- taining 
0.054 mL of anticoagulant EDTA, 4.5 mL volume for suction. The blood of 
each volunteer was centrifuged (1000 x g, 4 oC, 10 minutes) separately and 
later used to create a pool of plasmas. This pool was added with 
preservatives (2 mmol L-1 benzamidine,   0.5%   gentamycin,   0.25%   
chloramphenicol, 
0.5 mmol L-1  phenylmethylsulfonyl uoride and 0.1units per 
mL aprotinin), prior to freezing. 
LDL  (density  of  1006  ±  1063  g  mL-1)  was  isolated  by sequential 
ultracentrifugation at 100 000 x g for 20 h at 4 oC,27 using (VLDL: 12 h, 1.006 
g mL-1; LDL: 20 h, <1.063 g mL-1; 
HDL: 40 h, <1.21 g mL-1). LDL was dialyzed for 48 h in PBS buﬀer with 
0.01% EDTA and ltered (0.22 micron in diameter, Millipore). LDL 
preparations were stored at 4 oC. The protein content was measured by 
the Lowry's method.28 
 
 
2.5. Synthesis of oxLDL and its characterization 
The oxidation of LDL was carried out as described earlier,26,29 using native 
LDL from 4 to 6 mg mL-1. The LDL solution was then incubated in a 
solution of 20 mmol L-1  CuSO4  at 37 oC. The time of incubation was set to 
18 h, as the TBA content (an important indicator of lipid peroxidation) 
increased up to a maximum and reached a steady value a er this period of 
time. In addition, native LDL and oxLDL retention on ion exchange 
columns (Resource Q) in the fast protein liquid chromatography (FPLC) have  
shown increased  retention of  oxLDL  relative  to native LDL within this 
time of oxidation, correlated with an increased number of negatively 
charged particles. The oxidation of LDL was blocked with the addition of 1 
mmol L-1 EDTA. 
The oxLDL solutions displayed nanostructures with an average size 
of 67.7 nm f with a standard deviation of 65.6 nm, as determined by DLS 
measurements using Avid Nano DLS equipment. The expected average 
molecular weight for oxLDL was 85013.13 kDa, corresponding to a 
polydispersion % of 0.94. 
 
2.6. Synthesis of the plastic antibody material 
The synthesis of the MAPS material was divided into two parts, using two 
Au–SPEs where only the gold working areas of the electrodes were 
modi ed. All solutions were added a er washing out the surface with 
water or buﬀer from the previous one. All experiments were conducted 
at room temperature, except the incubation of oxLDL on Au–SPE/1 that 
was carried out at 4 oC. 
Au–SPE/1 was modi ed by drop-coating a plasticized PVC– COOH layer 
on the gold support. This polymer was then le  to dry for 1 day and modi ed 
by incubation in NHS for 10 minutes and subsequent reaction with EDAC/NHS 
solutions for 2 hours. oxLDL solution was added next and le  for 4 hours. The 
surface was then le  overnight with the charged monomers. Polymeri- 
zation was conducted for 5 hours by rst adding MAA and EGDMA 
solutions to the modi ed support, and then BPO. Finally, the surface 
was again similarly modi ed by the same EDAC/NHS reaction, and washed. 
Au–SPE/2 was modi ed by incubating the Au area with MPA for 20 hours. 
This new layer was subsequently incubated in NHS for 10 minutes and 
made react with EDAC/NHS solutions for 2 hours. EA solution was then 
added and le  for 1 hour. 
The surfaces of SPE/1 and SPE/2 where then aligned and held together 
under water for 24 h. Au–SPE/2 held the MAPS material that was further 
treated with proteinase K for 2 h and thor- oughly washed with water. 
NIM surfaces were prepared by using a similar protocol, where the 
addition of oxLDL and charged monomers was replaced by buﬀer/water. 
 
2.7. Electrochemical assays 
The MAPSs and NIMs were tested by incubating MAPS or NIM devices in 
oxLDL standard solutions of 2.5; 5.0; 7.5; 10.0; 12.5; 25.0; and/or 50.0 mg mL-
1. This incubation period was set to 15 minutes. The oxLDL solutions were 
prepared in buﬀer or in FCS solution,  using  these  solutions  as  the  blank  
of  the  corre- sponding standards. 
EIS spectra were recorded in 5.0 mmol L-1 iron redox couple 
solution. A standard potential of 0.12 V was applied for this purpose, 
using a sinusoidal potential perturbation of 0.01 V and 
50 frequencies logarithmically distributed over a frequency range of 
0.1–100 kHz. 
The selectivity of the MAPS surface was tested against native LDL, Myo 
and Hb solutions, of 50 mg mL-1  prepared in buﬀer. The surface was le  in 
contact with these up to a maximum of 1 h. 
 
3. Results and discussion 
3.1. Design of the sensory surface 
The synthesis of MAPS required two diﬀerent Au–SPEs. Au–SPE/ 1 was used to 
create the SPAM material, but ensuring that the 
  
 
 
 
Fig. 1  Assembly of the MAPS material by chemical modiﬁcation of two separate Au–SPEs. 
 
 
 
 
polymer layer was thick enough to cover the all template compounds 
present. Au–SPE/2 received this SPAM material in Au–SPE/1, exposing in 
this way the template layer that was linked to the rst SPE, which was 
indeed the MAPS sensory surface (playing an anti-oxLDL role). All chemical 
modi cations made are shown in Fig. 1. 
Au–SPE/1 was rst coated with a polymeric layer (Fig. 1A1). In order to 
ensure covalent binding of the oxLDL particles, where many –COOH and –
NH2 functions are present, this layer could be composed of amine or 
carboxylic acid functions. But this layer should also ensure a strong 
bonding to the Au support on one side and to the oxLDL template on the 
other side. A thin 
lm of plasticized poly(vinyl chloride) carboxylated (PVC– COOH) was 
found suitable for this purpose. This plasticized polymer showed rubber 
properties, and remained well attached to the Au working electrode. 
PVC–COOH solution prepared without the plasticizer, o-nitrophenyl octyl 
ether (oNPOE), was also tested, but the physical bond to the Au layer was 
not as eﬃcient. 
The –COOH groups on top of this layer were subsequently 
activated for covalent binding of the template. This was done by the well-
known N-(3-dimethylaminopropyl)-N0-ethylcarbo- diimide 
hydrochloride (EDAC)/N-hydroxysuccinimide (NHS) chemistry.30 This 
reaction leads to an ester intermediate that reacts promptly with any 
available amine group in oxLDL. The corresponding reactions may be 
followed by analogy in (ref. 31). Thus, once oxLDL was added to the Au–SPE/1 
surface, it bound readily to the formerly activated carboxylic groups, 
thereby forming an amide bond (Fig. 1A2). Ethylenediamine (EA) was 
added next to deactivate the –COOH groups that remained active a er 
binding the oxLDL particles (Fig. 1A2). 
The imprinting stage started by introducing charge labels around the 
oxLDL on the Au-SPE/1 (Fig. 1A3). This was achieved 
by a pre-monomeric arrangement established by means of 
ionic/electrostatic interactions between the accessible charged sites of the 
template located on the outer surface and vinyl monomers carrying 
charged groups. Vinyl benzoate (VB, polar) and VB+ (vinylbenzyl 
trimethylammonium chloride, positively charged) were used for this 
purpose. A er this, the surface was incubated in methacrylic acid (MAA) 
and ethylene glycol dimethacrylate (EDGMA), to proceed with the 
polymerization and formation of a rigid and highly reticulated matrix 
around the template. This polymerization was initiated by benzoyl 
peroxide (BPO), a radical species, thus avoiding the introduc- tion of 
unnecessary ionic charged species inside the polymeric matrix. This 
polymerization reaction was conducted for a long time, ensuring that 
oxLDL was completely covered by the newly formed polymer. The 
functional groups at the outer surface of Au–SPE-1 were now –COOR 
(ester) or –COOH. These groups were activated before binding this layer 
to the other SPEs, by following the same EDAC/NHS chemistry as 
previously indicated. 
Au–SPE-2 was prepared in parallel, making use of similar chemistry. 3-
Mercaptopropionic acid (MPA) was placed rst on Au. It comprised a three 
carbon chain with a carboxylic group (–COOH) on one end and a thiol 
function (–SH) on the other end. The contact between Au and –SH lead to 
the spontaneous formation of a strong Au–sulphur interaction and the 
formation of a stable carboxylic layer on the outer surface of the gold 
support (Fig. 1B1). This surface as further activated by EDAC/ NHS 
chemistry and added to ethylene diamine, in order to generate an 
amine layer at the outer surface of the Au–SPE/2 (Fig. 1B2). 
Au–SPE-1 and Au–SPE-2 were then joined by facing the sensory 
materials against each other and clipping the SPE supports (Fig. 1C). This 
combination was submerged in water, 
  
 
in order to ensure an aqueous environment for the reaction to proceed. At 
this stage, the activated groups in Au–SPE/1 were allowed to react with the 
amine groups in Au–SPE/2, binding the two SPEs together. 
Upon separation of the two SPEs, Au–SPE/1 kept the poly- meric layer 
and most probably part of the oxLDL covalently bound to it, while Au–
SPE/2 exposed a sensing layer where the ox-LDL bound to the polymer lm 
was placed at the same z-level (Fig. 1D). In this separation, it was highly 
probable that most parts of the template would remain in Au–SPE/1, 
because the polymeric network around it could have prevented the 
template from coming out connected to the PVC–COOH lm. Assuming 
such possibility, complete template removal was granted by incubating 
the sensing layer of SPE-2 in proteinase K. Proteinase K cleaved the 
peptide bonds of the template under mild conditions and subsequently 
destroyed the polypeptide structure inside the polymer (Fig. 1E). The 
template was thus removed without disrupting the existing polymeric 
matrix. The MAPS sensory surface was obtained a er removing the peptide 
fragments from the imprinted sites by thorough rinsing with buﬀer and 
water. 
 
3.2. Follow-up of the chemical modi cations on the Au–SPE 
Since the successive chemical modi cations of the area of the working   
electrode   changed   their   electrical   features,   the assembly of the anti-
oxLDL lm was followed-up indirectly by monitoring the electron transfer 
capability of the Au–SPE for the redox pair [Fe(CN)6]
4-/[Fe(CN)6]
3-. This 
was done by elec- trochemical impedance spectroscopy EIS, using the 
Randle's circuit for modelling the experimental data. This circuit was 
selected  for  being  the  simplest  and  the  most  frequently employed  
in  gold-based  immunosensing.32    It  comprises  the uncompensated 
resistance of the electrolyte (Rs), in series with the  capacitance  of  the  
dielectric  layer  (Cdl)  and  the  charge- transfer  resistance  (Rct,  inversely  
proportional  to  the  rate  of electron transfer), if a redox probe is 
present in the electro- chemical  cell.  The  two  latter  components  are  
connected  in parallel. An additional component, connected in series with 
Rct, the Warburg impedance (Zw), accounts for the diﬀusion of ions from 
the bulk electrolyte to the electrode interface. 
EIS data were presented in the form of Nyquist plots (Fig. 2). In this, the 
imaginary impedance component (Z00, out-of-phase) was plotted against 
the real impedance component (Z0, in- phase) at each frequency. As 
expected, these plots showed a semicircle region lying on the real axis 
at a high frequency range, indicating a charge-transfer controlled process 
in which its diameter (RCT) equalled the electron transfer kinetics of the 
redox-probe at the electrode interface. This region was followed by a linear 
behaviour in the lower frequency range, implying a mass-transfer limited 
process.32 
The bare gold support of Au–SPE/1 and Au–SPE/2 showed a very small 
semicircle domain, suggesting a very fast electron- transfer process with a 
diﬀusional limiting step (Fig. 2B). The consecutive attachment of the PVC–
COOH, oxLDL and polymer gave rise to consecutive increases in the 
electron transfer resistance, resulting in increases in the semicircular 
section of 
 
 
 
Fig. 2 EIS spectra of the chemical modiﬁcations on the supporting ﬁlm, 
acting as “backside” of the material (A, Au-SPE/1) and the 
subsequent assembly of the transducing-side part of the device, 
including its link to the back-side polymer, back-side removal and 
complete template exclusion (B, Au-SPE/2). 
 
 
 
the Nyquist plot (Fig. 2A). The binding of MPA to the Au in SPE/2 also 
contributed to a moderate RCT increase (Fig. 2B), as expected for thiol 
compounds of small carbon chains bound to gold. Compared to this, the 
subsequent binding of the polymer layer formed on SPE/1 promoted a 
huge increase in RCT. This increase was however much smaller than that 
observed in the original SPE/1, implying that the polymer transfer was 
not complete. Part of oxLDL was however present within this poly- mer lm 
in SPE/2, because the subsequent action of protease decreased the RCT 
value. The removal of oxLDL reduced the presence of negatively charged 
species in the polymeric lm, which decreased the resistance of a redox 
probe that was also negatively charged. 
The Raman spectra of MAPS and NIM materials were also recorded 
aiming to nd any chemical diﬀerences between these. According to 
the recorded spectra, no diﬀerences were observed between the 
corresponding biosensory surfaces. The obtained spectra are shown in Fig. 
3. 
  
 
 
 
 
Fig. 3    Raman spectra of the MAPS and NIM material. 
 
 
 
 
 
Fig. 4 SEM images of the non-imprinted surface (left, NIM) and imprinted 
material (right, MAPS). 
 
 
 
3.3. SEM studies 
NIM and MAPS were observed by scanning electron microscopy (SEM) and 
were shown as completely diﬀerent materials. The obtained images are 
displayed in Fig. 4. 
The MAPS surface showed a high density of “pores” of diﬀerent 
sizes (Fig. 4, right). These pores were the oxLDL binding sites, being 
correlated with the exit of the oxLDL from the polymeric network. This 
was supported by changes in the pore size, because it ranged in agreement 
with the range of sizes of the oxLDL template, as measured by dynamic light 
scattering (DLS). The average size was 67.7 nm f and the standard devi- 
ation was equal to 65.6 nm. 
NIM materials showed small agglomerates of the polymer on the 
surface (Fig. 4, le ). This observation was completely unexpected and 
may correspond to the presence of PVC–COOH residues remaining a er the 
separation of SPE/1 and SPE/2. 
 
3.4. Response of the materials against oxLDL 
The ability of the MPAS surface to interact with the targeted template 
was also followed by EIS. For this purpose, a solution 
of 50 mg mL-1 of oxLDL was placed in contact with this type of surface  for  
several  periods  of  time,  up  to  30  minutes.  In general, the RCT value of 
the blank surface (incubated in PBS) increased with the presence of 50 
mg mL-1. The maximum 
increase in RCT was observed a er 15 minutes of incubation and the 
resulting RCT value remained approximately constant for longer 
incubation periods. All further studies were con- ducted for a 15 
minute incubation period for oxLDL. The typical EIS spectra for PBS 
and oxLDL solutions are seen in Fig. 5A. 
The eﬀect of the imprinting process upon the electrical response of 
the material was further tested by comparing the response of the MAPS 
surface to the NIM one. Unexpectedly, the incubation of the material in PBS 
or in oxLDL gave rise to the same electrical signal (Fig. 5B). This meant that 
the NIM surface was unable to establish speci c/non-speci c interactions 
with the template. This was mostly surprising because the imprinted 
template was composed of diﬀerent species, bearing diﬀerent sizes. This 
behaviour indicated the absence of non-speci c binding in NIM surfaces 
and suggested a speci c response for the MAPS material. 
 
 
3.5. Selectivity study 
The ability of MAPS (plastic anti-oxLDL) to discriminate oxLDL 
nanostructures from parent or coexisting compounds in serum was  
checked  by  incubating  the  material  in  native  LDL, myoglobin (Myo) 
and human haemoglobin (Hb). This was done by placing a drop of the 
corresponding solution on the MAPS surface and incubating it for a 
suitable period of time. This study was conducted with solutions of 50 mg 
mL-1 of interfering species, the same concentration as that of the oxLDL 
solution, 
but higher concentrations than those expected in real serum. The time 
given for an aﬃnity reaction with the sensory material 
  
 
 
 
Fig. 5 EIS spectra of the MAPS and NIM with oxLDL solution of high 
concentration, prepared in buﬀer. 
 
 
 
 
was set to 1 hour, to strengthen its possible interaction with any interfering 
species. 
As may be seen in Fig. 6, Myo or Hb was unable to change the pro le of the 
oxLDL EIS spectrum (Fig. 6A and B). This result was extraordinary 
considering that the imprinted material was highly heterogeneous in size 
and chemical structure. Further- more, the MAPS surface was unable to 
react with side-proteins, not even by means of non-speci c interactions. 
The presence of native LDL on MAPS gave rise to a little increase in 
RCT (Fig. 6C). This little increase could have been correlated with the high 
structural similarity between native LDL and the corresponding 
imprinted oxidized fragments. However, there is a great chance that this 
observation re ects the small fraction of oxidized species existing in 
circulating LDL. 
Overall, the obtained selectivity data pointed out the possibility 
of using the MAPS material as a recognition surface for oxLDL 
determination in serum, and therefore in patients with normal or over-
concentration of the targeted antigens. 
 
 
 
Fig. 6  EIS spectra of the MAPS device in PBS buﬀer and in diﬀerent 
 side-biomolecules that may be present in serum.   
 
 
 
 
3.6. Sensing oxLDL in serum 
Considering that the anti-oxLDL surface should operate well in serum to be 
useful in clinical context, it is important to check the performance of the 
MAPS under close-to-real conditions. This was done by replacing the 
buﬀer in the standard solutions used to calibrate the EIS calibration of the 
MPAS-device by non- diluted FCS solutions (equal to the biological 
composition). FCS was used for this purpose because of its great 
similarity to human serum.33 
The EIS spectra of the MAPS surface tested with oxLDL in FCS solution 
showed clear evidence of the presence of oxLDL, leading to a signi cant 
increase in RCT. To ensure that this increase in RCT did not come from FCS, 
the individual signal of 
  
 
 
 
 
Fig. 7 EIS spectra of the MAPS device tested on an FCS background (A) and the corresponding calibration curve (B), plotting RCT experimental signals corrected 
against the signal of FCS in blank solutions. 
 
 
 
an FCS solution was measured by incubating the MAPS surface in a solution 
containing FCS and no human oxLDL (0 mg ml-1). As  may  be  seen  in  Fig.  7A,  
only  negligible  diﬀerences  were observed between this and PBS. This result 
is also in agreement with the great selectivity of the material reported in the 
previous point. 
The analytical performance of the immunosensor  in FCS solutions 
was checked by calibrating the device with oxLDL standards prepared in 
FCS. Since all samples would need at least one dilution step prior to 
analysis, diluted FCS was used for this purpose. The oxLDL concentration 
range was changed from 0.0 mg mL-1  (FCS without human oxLDL) up to 
50 mg mL-1. The typical EIS spectra are seen in Fig. 7B. The values of RCT 
plotted against concentration displayed a curved behaviour, very common to 
real antigen/antibody interaction and similar to Michaelis–Menten 
kinetics. For commodity reasons, results were linearized by plotting the 
logarithm concentration against relative RCT. Relative RCT  was used to 
correct any diﬀerences that may be observed in the active surface of 
diﬀerent MAPS– SPEs. The linear portion of the response was observed 
up to 
10  mg  mL-1,  and  a er  that  the  material  seemed  saturated 
(Fig. 7B). The linear response in FCS serum, and thus similar to real 
conditions, was observed from 2.5 to 10 mg mL-1. This region is within 
the normal range of oxLDL levels, meaning that the presented material 
oﬀers potential use in human serum having normal and higher levels of 
oxLDL. 
 
4. Conclusions 
This novel backside surface imprinting process, where the polymer 
thickness is no obstacle for the formation of binding sites, was proved 
successful for targeting a heterogeneous mixture of biomolecules 
generated by the oxidation of LDL. The material so prepared seemed to oﬀer 
a speci c response for the targeted antigens and a mechanistic 
response close    to 
biological systems. In general, the chemical functions that were used to 
assemble the binding sites are diﬀerent from the ones used to assemble 
the polymeric network around the template, leading to diﬀerent 
electrostatic environments inside and outside the binding position. 
Inside the binding sites, there are positive charges and polar functions 
that are expected to be exposed and to interact directly with the 
template. So, the interaction of oxLDL with the corresponding binding 
sites is promoted by electrostatic interactions, in a supramolecular 
arrangement that resembles ‘host–guest’ electrostatic interactions. 
Since the sensory surface is synthetic, it may also be reused to target 
new concentrations of oxLDL solution, lying in an upper or lower 
concentration range than the one tested before, provided that the surface is 
suitably washed. 
Overall, this MAPS concept opens a new path to generate plastic 
antibodies, creating new expectations in the possibility of generating 
synthetic materials acting close to monoclonal natural antibodies. The 
remarkable selectivity observed in MAPS may generate further a new 
line of devices for diagnosis in point-of-care of diﬀerent biomolecules of 
clinical relevance. Ultimately, MAPS sensory materials may replace the 
use of natural antibodies in conventional diagnosis (mostly ELISA) and 
contribute to save many animals that are today being used/ sacri ced solely 
for this purpose. 
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